The University of Chicago Header Logo

Connection

Jerry Krishnan to Biomarkers

Back to Details
This is a "connection" page, showing publications Jerry Krishnan has written about Biomarkers.
Jerry Krishnan
Connection Strength
0.835
Biomarkers
  1. Biomarkers to Predict Response to Inhaled Corticosteroids and Long-Acting Muscarinic Antagonists in Adolescents and Adults with Mild Persistent Asthma. Ann Am Thorac Soc. 2022 03; 19(3):372-380.
    View in: PubMed
    Score: 0.133
  2. PrecISE: Precision Medicine in Severe Asthma: An adaptive platform trial with biomarker ascertainment. J Allergy Clin Immunol. 2021 05; 147(5):1594-1601.
    View in: PubMed
    Score: 0.124
  3. Systemic Markers of Inflammation in Smokers With Symptoms Despite Preserved Spirometry in SPIROMICS. Chest. 2019 05; 155(5):908-917.
    View in: PubMed
    Score: 0.107
  4. Value of peripheral blood eosinophil markers to predict severity of asthma. BMC Pulm Med. 2016 07 29; 16(1):109.
    View in: PubMed
    Score: 0.090
  5. Association of Sputum Eosinophilia With Easily Measured Type-2 Inflammatory Biomarkers in Untreated Mild Persistent Asthma. J Allergy Clin Immunol Pract. 2024 Apr; 12(4):960-969.e6.
    View in: PubMed
    Score: 0.038
  6. A blood and bronchoalveolar lavage protein signature of rapid FEV1 decline in smoking-associated COPD. Sci Rep. 2023 05 22; 13(1):8228.
    View in: PubMed
    Score: 0.036
  7. The Precision Interventions for Severe and/or Exacerbation-Prone (PrecISE) Asthma Network: An overview of Network organization, procedures, and interventions. J Allergy Clin Immunol. 2022 02; 149(2):488-516.e9.
    View in: PubMed
    Score: 0.033
  8. Patterns and significance of exhaled-breath biomarkers in lung transplant recipients with acute allograft rejection. J Heart Lung Transplant. 2001 Nov; 20(11):1158-66.
    View in: PubMed
    Score: 0.033
  9. The precision interventions for severe and/or exacerbation-prone asthma (PrecISE) adaptive platform trial: statistical considerations. J Biopharm Stat. 2020 11 01; 30(6):1026-1037.
    View in: PubMed
    Score: 0.030
  10. Association of urine mitochondrial DNA with clinical measures of COPD in the SPIROMICS cohort. JCI Insight. 2020 02 13; 5(3).
    View in: PubMed
    Score: 0.029
  11. Associations Among 25-Hydroxyvitamin D Levels, Lung Function, and Exacerbation Outcomes in COPD: An Analysis of the SPIROMICS Cohort. Chest. 2020 04; 157(4):856-865.
    View in: PubMed
    Score: 0.029
  12. Adapting clinical trial design to maintain meaningful outcomes during a multicenter asthma trial in the precision medicine era. Contemp Clin Trials. 2019 02; 77:98-103.
    View in: PubMed
    Score: 0.027
  13. NT-proBNP in stable COPD and future exacerbation risk: Analysis of the SPIROMICS cohort. Respir Med. 2018 07; 140:87-93.
    View in: PubMed
    Score: 0.026
  14. Hospital Procalcitonin Testing and Antibiotic Treatment of Patients Admitted for Chronic Obstructive Pulmonary Disease Exacerbation. Ann Am Thorac Soc. 2017 Dec; 14(12):1779-1785.
    View in: PubMed
    Score: 0.025
  15. Frequency of exacerbations in patients with chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort. Lancet Respir Med. 2017 08; 5(8):619-626.
    View in: PubMed
    Score: 0.024
  16. Respiratory Symptoms Items from the COPD Assessment Test Identify Ever-Smokers with Preserved Lung Function at Higher Risk for Poor Respiratory Outcomes. An Analysis of the Subpopulations and Intermediate Outcome Measures in COPD Study Cohort. Ann Am Thorac Soc. 2017 May; 14(5):636-642.
    View in: PubMed
    Score: 0.024
  17. Progression to Uncontrolled Severe Asthma: A Novel Risk Equation. J Manag Care Spec Pharm. 2017 Jan; 23(1):44-50.
    View in: PubMed
    Score: 0.023
  18. Primary angiosarcoma of the spleen. A clinicopathologic study of 40 cases. Am J Surg Pathol. 1993 Oct; 17(10):959-70.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.